Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Harris

Showing results (21-30 of 137) with videos related to

Pageof 14
Sort By:
Methods (San Diego, Calif.)|December 1, 2010
A Drug-Based Cellular Assay (DBCA) for studying cytotoxic and cytoprotective activities of the prion protein: A practical guideTania Massignan, Emiliano Biasini, David A Harris
Expert Reviews in Molecular Medicine|April 9, 2016
Mechanisms of prion-induced neurodegenerationPaula Saá, David A Harris, Larisa Cervenakova
Prion|September 30, 2017
An inter-domain regulatory mechanism controls toxic activities of PrP<sup>C</sup>Alex J McDonald, Bei Wu, David A Harris
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 30, 2011
A nine amino acid domain is essential for mutant prion protein toxicityLaura Westergard, Jessie A Turnbaugh, David A Harris
Prion|March 29, 2012
Ion channels induced by the prion protein: mediators of neurotoxicityIsaac H Solomon, Emiliano Biasini, David A Harris
The Journal of Biological Chemistry|October 26, 2011
A naturally occurring C-terminal fragment of the prion protein (PrP) delays disease and acts as a dominant-negative inhibitor of PrPSc formationLaura Westergard, Jessie A Turnbaugh, David A Harris
Biochimica Et Biophysica Acta|April 25, 2007
The cellular prion protein (PrP(C)): its physiological function and role in diseaseLaura Westergard, Heather M Christensen, David A Harris
The Journal of Biological Chemistry|June 25, 2010
Neurotoxic mutants of the prion protein induce spontaneous ionic currents in cultured cellsIsaac H Solomon, James E Huettner, David A Harris
JAMA Surgery|August 27, 2025
The GLP-1 Era-What Comes After Bariatric Surgery?Kate V Lauer, David A Harris, Luke M Funk
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|March 4, 2022
Comment on: The APB study: apixaban pharmacokinetics in bariatric patients before to 1 year after vertical sleeve gastrectomy or Roux-en-Y gastric bypassJacqueline A Murtha, David A Harris, Luke M Funk
Pageof 14

Showing results (21-30 of 137) with videos related to

Sort By:
Pageof 14
Methods (San Diego, Calif.)|December 1, 2010
A Drug-Based Cellular Assay (DBCA) for studying cytotoxic and cytoprotective activities of the prion protein: A practical guideTania Massignan, Emiliano Biasini, David A Harris
Expert Reviews in Molecular Medicine|April 9, 2016
Mechanisms of prion-induced neurodegenerationPaula Saá, David A Harris, Larisa Cervenakova
Prion|September 30, 2017
An inter-domain regulatory mechanism controls toxic activities of PrP<sup>C</sup>Alex J McDonald, Bei Wu, David A Harris
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 30, 2011
A nine amino acid domain is essential for mutant prion protein toxicityLaura Westergard, Jessie A Turnbaugh, David A Harris
Prion|March 29, 2012
Ion channels induced by the prion protein: mediators of neurotoxicityIsaac H Solomon, Emiliano Biasini, David A Harris
The Journal of Biological Chemistry|October 26, 2011
A naturally occurring C-terminal fragment of the prion protein (PrP) delays disease and acts as a dominant-negative inhibitor of PrPSc formationLaura Westergard, Jessie A Turnbaugh, David A Harris
Biochimica Et Biophysica Acta|April 25, 2007
The cellular prion protein (PrP(C)): its physiological function and role in diseaseLaura Westergard, Heather M Christensen, David A Harris
The Journal of Biological Chemistry|June 25, 2010
Neurotoxic mutants of the prion protein induce spontaneous ionic currents in cultured cellsIsaac H Solomon, James E Huettner, David A Harris
JAMA Surgery|August 27, 2025
The GLP-1 Era-What Comes After Bariatric Surgery?Kate V Lauer, David A Harris, Luke M Funk
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|March 4, 2022
Comment on: The APB study: apixaban pharmacokinetics in bariatric patients before to 1 year after vertical sleeve gastrectomy or Roux-en-Y gastric bypassJacqueline A Murtha, David A Harris, Luke M Funk
Pageof 14